IMVT Immunovant Corp Year-over-year net earnings per share growth for the last 12 months
Immunovant, Inc. leverages unique antibodies for global market capture in the autoimmune pathology therapy sector. Analyzing the quarterly earnings per share growth rate on GURU.Markets, we note that the metric value is 35.00. The business is independent of GDP cycles, and its value grows through the creation of innovative treatments for rare diseases.
Summary analytical data breakdowns for immunovant.com (IMVT)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Immunovant, Inc.|IMVT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Immunovant Inc|IMVT - Company Total Debt|Debt to Book Capitalization Ratio Immunovant, Inc.|IMVT - Company Long-Term Liabilities|Company Current Liabilities Immunovant|Quick Liquidity immunovant.com
- earnings and market multiples details:
IMVT - Company Profit|Expected Profit Immunovant, Inc.|IMVT - Market Cap to Earnings|Projected Price to Earnings Immunovant, Inc.|IMVT - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Immunovant Therapeutics|IMVT - Operating profit EBITDA|Earnings per share for the last twelve months Immunovant|IMVT - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months immunovant.com|IMVT - Net earnings per one share growth for the current year|Expected earnings per share growth for next year Immunovant, Inc.
- company sales and revenue statistics:
Basic company analysis:Immunovant, Inc.
Immunovant, Inc. maintains a high reputation for developing innovative therapies for autoimmune pathologies. This quarterly percentage increase in earnings per share measures the dynamics of net income divided by the number of shares. A positive trend signals the monetization of scientific achievements and the efficiency of the operating model. It is critical for investors to compare growth rates with R&D expenditures. Sharp spikes on this chart may indicate a risk of asset overvaluation.
Main competitors
argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Kiniksa - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Earnings per share growth in annualized terms for the last twelve months|celldex.com - Quarterly EPS earnings growth|AUPH - Quarterly EPS earnings growth|BCRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Pharvaris Pharma|Quarterly EPS earnings growth ABCL|TRML (tourmalinebio.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PGEN (Precigen Inc)|PHAR - Year-over-year net earnings per share growth for the last 12 months|NKTR - Year-over-year earnings per share growth for the last twelve months|UPB - Quarterly EPS earnings growth|ZBIO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Immunome, Inc.|Year-over-year earnings per share growth for the last twelve months Gossamer Bio|Quarterly EPS earnings growth KalVista Pharmaceuticals Inc|Year-over-year net earnings per share growth for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SVRA (savarapharma.com)|Year-over-year earnings per one share growth for the last 12 months RIGL|ANAB: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ATXS (Astria Therapeutics, Inc.)|ENGN: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Year-over-year earnings per share growth for the last twelve months aerovatetx.com|Quarterly EPS earnings growth aclaristx.com|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|Year-over-year net earnings per share change for the last twelve months Tiziana Life Sciences Ltd|Quarterly EPS earnings growth CABA (Cabaletta Bio Inc)|VTYX: Year-over-year earnings per share growth for the last 12 months|Theratechnologies, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Agenus Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Climb Bio|Quarterly EPS earnings growth Zura Bio Ltd|Year-over-year net earnings per share growth for the last 12 months ATYR (aTyr Pharma Inc)|Year-over-year net earnings per share change for the last twelve months Adagene Inc|Year-over-year earnings per share growth for the last twelve months ImageneBio Inc IMA|Year-over-year earnings per share growth rate for the last twelve months STTK (shattucklabs.com)|EQ: Year-over-year net earnings per share growth for the last 12 months|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Biotherapeutics (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|Quarterly EPS earnings growth X4 Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Adicet Bio Inc. (ACET)|Year-over-year net earnings per share growth for the last 12 months Celularity CELU|Quarterly EPS earnings growth INMB (INmune Bio Corporation)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months
